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Abstract
Scar-related VT is caused by local short circuits of electrical propagation
formed by slow-conducting channels of surviving tissue within a scar. Catheter
ablation treats scar-related VT by destroying the critical channel of surviving tissues. Its efficacy heavily relies on how well the channels critical to the
formation of VT circuits can be localized. Unfortunately, in current practice,
this relies on invasive catheter mapping that falls short in several critical aspects: up to 90% of the VT circuits are too short-lived to be mapped, the
mapping cannot be done non-invasively prior to the ablation procedure, and
the mapping is restricted to one heart surface at a time.
Electrocardiographic imaging (ECGi) is a noninvasive approach that reconstructs cardiac electrical signals from a very dense body surface electrocardiogram (ECG) in combination with patient-specific geometries of the heart and
torso. In this dissertation, we investigate the clinical utility of ECGi in guiding catheter ablation of scar-related VT. Specifically, we investigate two open
questions that are not well-understood in the potential of ECGi for mapping
VT circuits. First, instead of commonly-used epicardial ECGi, we investigate
the validity of simultaneous epicardial and endocardial ECGi mapping of VT
circuits, and the possibility of using information from these two surfaces to
infer the morphology of 3D circuits. Second, we investigate the integration of
ECGi electrical information of VT circuits with magnetic resonance imaging
iv

v

(MRI) of scar analysis for joint electrical and structural delineation of the
substrates for VT circuits. These studies were performed on a combination of
computer simulation, animal model, and human subject data.
Experimental results showed that epi-endo ECGi mapping could reconstruct VT circuits, differentiate 2D versus 3D circuits, and provide information
about the location of the VT circuit beneath the surface. They also showed
that integrated MRI-ECGi analysis offered a quantitative characterization of
the scar substrate that forms a VT circuit. These outcomes showed that simultaneous epi-endo ECGi in the combination of MRI structural scar imaging
may provide a viable augmentation to the current practice of invasive catheter
mapping. It may help clinicians plan for the ablation prior to the procedure
by equipping them with knowledge about a VT circuit’s critical components,
the surfaces that are involved, and the 3D morphology of the VT circuit.
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Chapter 1

Introduction
1.1

Overview

Electrical activation of the heart muscle triggers the contraction of the muscle [6]. Therefore, a coordinated propagation of electrical activation in the
heart is the premise for a rhythmic contraction of the heart to effectively pump
the blood [7]. Monomorphic ventricular tachycardia (VT) involves a short
circuit of electrical activation that rotates around a substrate in a fast manner [8]. Such circuits are formed by narrow channels of surviving tissue inside
the scar [9]. These circuits (known as reentrant circuits) are life-threatening
because they diminish the ability of the heart to contract or pump blood [10].
Reentrant VT circuits are formed by narrow channels of surviving tissue
inside the scar. An effective treatment to VT is thus to destroy the circuits by
targeting the responsible channel with catheter ablation [9]. To identify the
region of the myocardial scar that contains the critical channel for reentrant
circuits (known as arrhythmogenic scar substrate), invasive contact mapping
techniques are currently used. However, contact mapping has multiple limitations, including providing an imperfect surrogate for a complex intramural 3D
pattern of electrical activation, limited spatial resolution, long mapping time,
and potential low voltage measurements due to poor catheter contact [11].
Electrocardiographic imaging (ECGi) is a noninvasive approach that reconstructs cardiac electrical signals from a very dense body surface electrocardiogram (ECG) in combination with patient-specific geometries of the heart and
1
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torso. ECGi can simultaneously reconstruct epicardial and endocardial electrical signals and rapidly map arrhythmia episodes that are too short-lived for
contact mapping. In this research, we investigate the clinical utility of ECGi
in providing functional data of reentrant circuits that are currently missing in
informing clinical practice.

1.2

Problem Definition

Invasive mapping techniques are routinely used to map the reentrant VT circuit and identify scar locations and targets for catcher ablation. More specifically, when reentrant VT circuits can be induced and tolerated for sufficiently
long by the patient, activation mapping and entrainment pacing techniques
can be applied to pinpoint the re-entry circuit’s critical channel (known as
isthmus) and from where it enters and exits the car (known as entrance and
exit sites). This, however, is only possible in 10% of the VTs [12] and often
only maps the reentrant circuits at one surface of the heart. One recent study,
employing epicardial-and-endocardial contact mapping, explained the partial
view of the reentrant circuits observed on the surface and highlighted the importance of understanding the 3D nature of the VT circuit [13]. However, such
joint epicardial-and-endocardial contact mapping is challenging and only possible in a small number of medical centers. For the vast majority of the VTs,
substrate mapping during sinus or paced rhythm have to be used to identify
regions of myocardial scar as well as potential critical sites to the VT. These
results, however are again restricted to heart surfaces and– due to the lack of
data regarding the functional circuit – often do not pinpoint the sites specific
to the formation of a reentrant circuit.
There has been an increasing interest in the potential of delayed contrastenhanced magnetic resonance imaging (DCE-MRI) technique in guiding catheter
ablation for VT [14]. This is mainly owing to its ability to image the 3D heterogeneous structure of myocardial scar in high resolution, including the surviving
tissues (as a gray zone) inside the scar core [15]. However, while there may
be a large extent of heterogeneous tissues inside the myocardial scar, identifying the specific channel critical to a VT circuit may require a combination of
structural and electrical data.
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ECGi, due to its noninvasive nature, shows great potential in augmenting contact mapping by providing rapid mapping of VT reentrant circuits.
The use of ECGi in mapping scar-related VT has been considered in a small
number of existing studies. For mapping VT substrates, ECGi was used to
delineate myocardial scar in post-infarction hearts electrically [16] [17]. Research showed that ECGi can reveal low-amplitude signal characteristics, such
as signal fractionation, that suggest potential critical sites within and around
the scar. For mapping VT circuits, investigations included two case studies
of post-infarction canine hearts placed inside a torso tank [18] [19] and three
human studies [20] [21] [22], all limited to epicardial VT mapping only. These
existing studies leave two important open questions.
First, mapping only one surface at a time using ECGi could lead to losing useful information about the VT circuit that may be buried beneath that
surface. Instead, acquiring information about the VT circuit from both the
epicardial and endocardial surfaces may enable and improve inference of the
3D morphology of a VT circuit beneath the surface. Second, previous ECGi
studies focus only on the constructed signals from ECG without considering
any other structural data about the scar substrates. Combining ECGi electrical information of the VT circuit with other modalities may help improve the
accuracy of localizing VT circuit locations. Neither of these two questions has
been addressed in existing studies.

1.3

Research Questions

In this research, we focus on the clinical utility of ECGi in understanding and
improving the ablation of scar-related VT circuits. Specifically, we address
the two critical gaps identified above in the research of ECGi in scar-related
VT: 1) the ability of simultaneous epi-endo ECGi (reconstructing signals on
the outer and inner layers of the heart) in revealing the 3D morphology of
reentrant circuits, and 2) the integration of ECGi and MRI for delineating the
critical channel for reentrant circuits.
The key contributions of this research can be summarized are as follows:
• Instead of commonly-used epicardial ECGi, we investigate simultaneous
epi-endo ECGi’s ability to reveal the morphology of the 3D reentrant
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circuits. To this end, we first evaluated the general validity of the global
VT activation patterns and substrates obtained by ECGi on both heart
surfaces. Evaluations were based on human data where knowledge about
the VT circuits was limited to voltage mapping of scar substrates and ablation sites obtained during clinical procedures. Second, we investigated
the possibility of using epi-endo ECGi to infer the morphology of 3D
reentrant circuits. In this direction, we first used epi-endo ECGi results
to categorize the 3D construct of a reentrant circuit, and then explored
the possibility to combine the epi-endo ECGi results to infer the critical
sites of a reentrant circuit inside the heart wall. Evaluations were based
on high-fidelity simulated VT circuits, where detailed 3D morphology,
including all the critical components of the VT circuits, were available.
• To better delineate substrate by joint electrical and structural mapping,
we introduced a novel analysis that presented a first step towards understanding VT’s critical channel by combining MRI scar analysis with
ECGi electrical information of VT circuits. In this direction, we first
quantified the association of ECGi-reconstructed electrogram characteristics to scar core, gray zone, and viable myocardium delineated from
DCE-CMR. Then, we analyzed ECGi-reconstructed VT circuits concerning 3D surviving channels inside the myocardial scar. Evaluations
were based on an animal model of post-infarction VT circuits, where 3D
scar architecture and potential critical channels of slow conduction were
available from joint MRI and voltage mapping data.
In the first direction, we were able to demonstrate that epi-endo ECGi
mapping could reconstruct recurrent VT circuits, differentiate 2D versus 3D
circuits, and provide information about the location of the VT circuit beneath
the surface by combining the epi-endo information. In the second direction,
we quantitatively showed that integrated MRI-ECGi analysis offers essential
information into the critical components that form a VT circuit. The outcome
of this research showed that simultaneous epi-endo ECGi in the combination
of MRI structural scar imaging may provide a viable augmentation to the
current practice of invasive catheter mapping in enabling morphology analysis
and localization of 3D reentrant circuits that are too short-lived for contact
mapping. These findings will help clinicians plan for the ablation prior to the
treatment procedure by equipping them with knowledge about the VT circuit’s
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critical components, the surfaces that are involved, and the 3D morphology of
the VT circuit.

1.4

Dissertation Organization

This dissertation is organized as follows: Chapter 2 reviews the basic background of cardiac electrophysiology. Chapter 3 provides the foundation of
ECGi including its forward and inverse formulations. Chapter 4 describes in
detail the non-invasive epi-endo ECGi. Chapter 5 describes the delineation of
3D reentrant circuits utilizing epi-endo ECGi. Chapter 6 describes the association of noninvasive ECGi with MRI scar imaging. Chapter 7 concludes this
dissertation and presents future directions that can be built on the ideas of
this dissertations.

Chapter 2

Background
2.1

Cardiac Electrophysiology

The heart is an electromechanical system located in the rib cage between
the right and left lungs. It is responsible for supplying the body’s metabolic
needs by pumping blood to and from all necessary tissues. The heart is made
up of four chambers — two upper chambers (atria) and two lower chambers
(ventricles), as shown in F igure 2.1. The contractions of those chambers are
coordinated by an electrical conduction system, which regulates the heart’s
pumping action.
An electrical stimulus is generated by a natural pacemaker called the sinus node (also called the sinoatrial node, or SA node). This node is located
in the right upper chamber (atria) of the heart. The two upper chambers of
the heart (atria) are stimulated first and contract for a short period of time
before the two lower chambers of the heart (ventricles). Under normal conditions, the sinus node generates an electrical stimulus regularly, 60 to 100
times per minute. Then those electrical stimuli activate the atria, and then
they travel down through the conduction pathways (bundle of his carries the
signal to the Purkinje fibers to the ventricles) and cause the heart’s ventricles
to contract and pump out blood. Each contraction of the ventricles represents
one heartbeat. The contraction of the atria happens in a fraction of a second
right before the ventricles, so their blood moves to the ventricles before the
ventricles contract.
6
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Figure 2.1: An interior view of the frontal section of the human heart [1].
.

The stander 12-lead ECG is the most widely used non-invasive cardiac electrophysiology (EP) imaging method, which was discovered by Einthoven [23].
This non-invasive technique acquires body-surface potential and translates the
electrical impulse generated by the polarization and depolarization of cardiac
tissue into a wave-form to be used by clinicians to understand the cardiac
conduction system. F igure 2.2A illustrates the standard 12-lead ECG that
allocates six precordial leads on the anterior thorax and three leads on the right
and left arm and left leg– to represent the ground. F igure 2.2B shows that the
conduction of the electrical impulses can be seen on the electrocardiography
(ECG), where the propagation of the electrical impulses from the right to the
left atrium is represented as a P wave. Then after the atriums, the electrical
impulses travel via specialized pathways, known as internodal tracts, from the
SA node to the atrioventricular node or AV node to activate the ventricular. The AV node causes a critical delay in the conduction system to prevent
the atria and ventricles from contracting simultaneously. The PR segment on
ECG represents the delay in the AV node and part of atrial repolarization.
Then the electrical impulses travel via the bundle of His (two bundle branches)
to the Purkinje fibers, which stimulate individual groups of myocardial cells to
contract. The spread of electrical activity through the ventricular myocardium
produces the QRS complex on the ECG. Atrial repolarization occurs and is

CHAPTER 2. BACKGROUND

8

Figure 2.2: ECG 12-Lead-Diagram and components, (A) standard 12-lead
ECG that allocates six precordial leads on the anterior thorax [2], (B)
schematic diagram of normal sinus rhythm for a human heart as seen on
ECG [3].
.

masked during the QRS complex by ventricular depolarization on the ECG.
The other part of the ECG signal is the ST segment, which normally represents
an electrically neutral area between ventricular depolarization (QRS complex)
and repolarization (T wave). Such a segment helps clinicians identify whether
there’s significant injury or insult to the myocardium. Understanding this part
of the ECG is essential for clinicians, where differential diagnosis for variations
in the ST segment morphologies (ST elevation or depression) could be critical
for clinical management where it can influence treatment. The last part of the
ECG is the T wave, which represents ventricular repolarization. The changes
in the T wave could be associated with a broad differential diagnosis, such as
it could be related to a life-threatening disease or provide clues to an otherwise
obscure illness.

2.2

Ventricular Tachycardia Electrophysiology

Ventricular tachycardia (VT) is a type of abnormal heart arrhythmia. It occurs when the heart’s lower chamber beats too fast to pump well, and the
body doesn’t receive enough oxygenated blood. A normal heartbeat begins
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with an electrical impulse from the sinus node. Ventricular tachycardia starts
in the lower chambers (ventricles) and is quite fast. If it lasts only a few seconds, ventricular tachycardia may cause no problems. But when sustained,
ventricular tachycardia can lower the blood pressure and cause cardiac arrest
in patients with structural heart disease, including ischemic and nonischemic
cardiomyopathies [24, 25]
F igure 2.3 illustrates the difference between the ventricular tachycardia
rhythm (abnormal) and the sinus rhythm (normal), where the VT QRS complex appears to be very different from the sinus rhythm. The VT QRS duration
is beyond 120 milliseconds, originating in the ventricles at a rate of greater
than 100 beats per minute. This can be hemodynamically unstable, causing
severe hypotension, and can thus be life-threatening if action is not taken immediately.
There are different forms of the VT, but the most dangerous type is the
scar-related VT, which contributes to over 350,000 sudden cardiac deaths each
year in the US [26]. This VT is caused by reentrant circuits formed by surviving tissue located within scar regions [27, 28]. As shown in F igure 2.4A, the
electrical impulses travel through the healthy heart muscles until it reaches the
scar, where it can not propagate except through narrow strands of surviving
tissue made of the entrance into the scar, isthmus inside the scar, and the exit
from the scar. As a result, the electrical impulse travels in a loop, forming a
circular pattern [29]. Each repeat excursion of the activation around the circuit defines a cycle of VT. The speed for the electrical impulses changes at the
entrance and exit of circuit regions where conduction slowing can occur, while
conduction within the isthmus itself can have near-normal properties [24]. The
electrograms in the isthmus region are typically low in voltage with multiple
deflections. Also, the electrograms tend to be relatively short in duration [30].
Identifying those critical components of the VT circuits, especially the isthmus
or exits as shown in F igure 2.4B, can help target appropriate intervention to
destroy the VT circuit and prevent future VT episodes.
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Figure 2.3: Different heart rhythms, (A) normal rhythm pathway and the
sinus rhythm’s signals, (B) abnormal rhythm pathway and the VT rhythm’s
signals [4].
.

2.3

Catheter Mapping and Ablation

Catheter ablation is a procedure that targets the critical components of the
VT circuit by inserting a long, thin wire into the heart chambers through the
veins. This treatment has been used for heart rhythm disorders for more than
25 years, where clinicians identify sites that are critical to the arrhythmia first,
and then they apply radiofrequency energy to those sites, causing a small burn
about 4–5 mm in diameter [31]. Clinicians might have to burn more than once
based on the patient’s arrhythmia. In case of the presence of the scar, clinicians may have to burn within the scar and around it to ablate the abnormal
electrical circuit responsible for the VT. Even though the catheter ablation is
considered as an effective solution showing interesting results in treating the
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Figure 2.4: Schematic illustration of a VT reentry circuit.

isolated channels of surviving myocardium within the scar [8] and preventing
its recurrence, the success of the ablation always relies on the mapping technique used to identify the sites of critical VT circuits.
In order to assess the location of scarring, if any, in the heart, magnetic
resonance imaging (MRI) is traditionally used to identify the scar. However,
MRI is contraindicated in patients with an implanted cardioverter defibrillator
(ICD), thus it can not be applied on all the patients unless it is performed at
experienced centers under close supervision. More importantly, MRI does not
provide the electrical information necessary to identify the VT circuits.
Most routinely, contact (invasive) mapping is done during the ablation to
help reveal locations of the scar and the site critical to the formation of reentrant VT. Two types of mapping techniques can be done depending on the
stability of the VT. Substrate mapping: is applied when the VT is unstable
– when the patient can not tolerate the clinical (induced) VT. It is used to
identify regions of scar and potential reentry circuit channels during stable sinus or paced rhythm. Voltage maps are created from 3-dimensional anatomic
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plots of electrogram amplitude. By adjusting the threshold of the voltage to
(0.5 to 1.5 mV) [32], this map can help identify areas of scar and areas of the
surviving tissue inside the scar, but is usually too large for ablation of the
entire region. Thus, clinicians try the pacing in a channel, which produces a
QRS that emerges after a delay due to slow conduction through the channel.
In another word, when the stimulated wavefront propagates through a reentry
circuit exit, the paced QRS morphology resembles VT, suggesting that the
pacing site is in a reentry circuit isthmus [33]. However, there are challenges
to point-by-point contact mapping, in part, due to its invasive nature: collecting data takes a long time, and it does not allow non-invasive planning prior
to the ablation procedure because it is done during the procedure.
When VT is stable for mapping, an isthmus can be mapped and targeted
during induced VT [34, 35]. The invasive mapping systems can provide two
types of mapping that can help identify VT circuits’ locations: 1) the activation time sequence maps, where the early activation refer to the VT exit
region, and 2) the entrainment mapping, which enables the diagnosis and characterization of reentrant arrhythmias from analysis of the specific interaction
between pacing maneuvers and tachycardia [8]. Mapping complex re-entry
pathways using the entrainment mapping helps the clinicians to decide the
relation of pacing sites to the re-entry circuit and discrimination of relevant
re-entry parts from bystander areas. The downside of invasive mappings is
that they take a long time to collect data point-by-point from different locations of the heart and this required the VT to be induced for the same amount
of time. Unfortunately, 90% of the patients can not tolerate the induced VT
for that long.
In summary, while the mechanism of reentrant VT circuits and the approach to target them are well understood, there is a critical lack of techniques in the current clinical practice for mapping and identifying the critical
components of reentrant circuits. Developments and evaluations of such techniques have the potential to significantly improve the success rate, safety, and
efficiency of catheter ablation of VT.

Chapter 3

Foundation of ECGi
Electrocardiographic imaging (ECGi) is an emerging noninvasive approach to
reconstruct cardiac electrical signals, using high-density surface electrocardiograms (ECG) in combination with patient-specific heart-torso geometry. In
this chapter, we first introduce the theoretical foundation of ECGi and then
describe the technical pipeline of ECGi as the general foundation of the research works described in the subsequent chapters of this dissertation.

3.1
3.1.1

Theoretical Foundation of ECGi
The Forward Problem of ECGi

The relationship between the electrical activity in the heart and body surface
potential defines the forward problem of electrocardiography. This relationship
is governed by quasi-static electromagnetic theory as described below:
∇.((Dint + Dext )∇φe (r)) = ∇.(−Dint ∇u(r)), ∀r ∈ Ωh

(3.1)

∇.(Di ∇φi (r)) = 0, ∀r ∈ Ωi , ∪Ωi = Ωt/h

(3.2)

The potential φe within the myocardium Ωh is originated from the spatial
gradient of action potential u described by this Equation (3.1), where the r
represents the spatial coordinate, Dint and Dext are the effective intracellular
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and extracellular conductivity tensors, and the bulk conductivity tensor is calculated as the summation of Dk = Dint + Dext . In the region Ωt/h bounded
by the heart’s surfaces and body surface, assuming there is no other active
electrical source exists within the torso, Equation (3.2) shows how the potential φi distributes within the volume conductor Ωi external to the heart with
conductivity tensor Di . The magnitude of anisotropic ratio of Dk is smaller
than that of Dint [36, 37]. Thus, converting Dk to scalars σblk and Di to
scalars φi can be done by assuming isotropic bulk and torso conductivity and
only retaining the intracellular anisotropy. Dint can be obtained using a 3D
experimentally-derived mathematical fiber model to the ventricular geometry
of the subject. The longitudinal direction of Dint is around 0.24 Sm−1 and
transversal direction is about 0.024 Sm−1 [38]. The intermediate value between longitudinal and transversal conductivities (0.48 Sm−1 and 0.12 Sm−1 ,
respectively) is used to calculate the isotropic bulk conductivity σblk . The conductivity value σt of a homogeneous torso is assumed to be 0.2Sm1 [38]. These
assumptions help describe the the forward relationship between cardiac action
potential u and body-surface voltage φ by the following Poisson’s Equation
(3.3) within the heart and Laplace’s Equation (3.4) external to the heart:
σblk ∇2 φe (r) = ∇.(−Dint ∇u(r)), ∀r ∈ Ωh

(3.3)

σt ∇2 φ(r) = 0, ∀r ∈ Ωt/h

(3.4)

The boundary condition on the heart surface Γh is defined in a way that help
maintain the continuity of potentials on the interface:
φe (r) = φ(r), ∀r ∈ Γh
(3.5)
∂φe (r)
∂u(r)
∂φ(r)
σblk
+ Dint
= σt
∂n
∂n
∂n
To maintain the continuity of potentials on the torso surface, a boundary
condition on the torso surface Γt is defined as:
∂φ(r)
= 0, ∀r ∈ Γt
∂n

(3.6)

Depending on the source model of choice, the above governing equations (3.1)
(3.6) can be solved on a discrete mesh of the heart and torso geometry in
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different forms. Common source models include extracellular potential on the
heart surface [18, 39], activation time on the heart surface [8], distributed current dipoles [40], and transmembrane potential or current density throughout
the 3D myocardium [41]. In this dissertation research, we focus on extracellular potential on the epicardial and endocardial surface as the source model:
this is one of the most classic source models in ECGi of which the epicardial
version has been used in the commercialized system [42]. In this case, the
governing equation consists of only Laplace’s equation and can be solved on
any given heart and torso geometry using proper numerical methods such as
the boundary element method [41] to obtain:
φb (t) = Hφv (t)

(3.7)

where the forward operator H relates extracellular potential φv (t) at ventricular epicardial and endocardial surfaces to body-surface potential φb (t) at each
time instant. H is specific to the given heart and torso geometry and is typically assumed to be time-invariant in ECGi research.

3.1.2

The Inverse Problem of ECGi

The inverse problem of electrocardiography seeks to obtain an estimation of
φv (t) from measurements of φb (t). This problem is ill-posed and its solution is
highly unstable with respect to measurement errors and noise. A large number
of inverse methods for ECGi have been developed in the last several decades,
considering various approaches to reduce the ill-posedness of the problem designed for different source models of choice [19,43,44,45,46]. When the source
model is extracellular potential on the heart surface, examples of regularization methods used to solve the inverse problem include truncated-SVD [47],
state-space filtering framework (Kalman filter) [48], and Tikhonov regularization (zero-order, first-order, second-order) [49].
In this desertion, to focus on the clinical utility of ECGi, we focus on a
most-commonly used approach to reconstructing the extracellular potential
on the epicardium and endocardium of the ventricles. Given body-surface
ECG data φb (t) and the subject-specific forward matrix H, the extracellular
potential on both the epicardial and endocardial layers can be reconstructed
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as:
φ̂v (t) = argmaxφv (t){||φb (t)−Hφv (t)||22 +λ||Lφv (t)||22 }

∀t ∈ {1, ..., T } (3.8)

where L is a Laplacian matrix on the ventricular surface, and λ is the regularization parameter that controls the strength of the regularization. The
optimization across all time instants is carried out independently. The first
term of Equation (3.8) seeks a solution of φv (t) that will best fit the surface
ECG data; the second term of Equation (3.8) enforces a local smoothness of
the spatial distribution of φv (t). The regularization parameter λ is empirically
determined.

3.2

ECGi Pipeline

F igure 3.1.2 outlines the ECGi pipeline that includes three main components:
pre-processing of the ECGs recorded from the body surface, construction of the
subject-specific heart-torso geometry, and the forward modeling and inverse
reconstruction process following the theory described in the previous section.

3.2.1

ECG Processing

In this dissertation research, all surface ECG data are collected following the
123-lead protocol developed in the Dalhousie University [50]. The ECG signal
recording system [5] consists of 123 leads: 120 torso electrodes with layout
as shown in F igure 3.2, and three limb electrode sites. The electrodes are
separated 5 cm from each other and attached to flexible rubber strips. The
position of the electrodes on the torso is determined by placing the fourth electrode from the bottom at the level of the fourth intercostal space parasternal.
The strips of the electrodes are placed on the front and back of the torso: the
first 12 strips are placed on the front from right to left and strips from 13 to 18
are placed on the back of the torso from left to right. In specific, Strips 1 and
12 are placed in the right and left mid-axillary lines. Strip 11 is placed in the
left anterior axillary line and strip 13 is also placed in the posterior axillary
line. Strips 4 and 6 are located in the V1 and V2 locations, respectively. Strip
5 is located over the sternum, while strips from 7 to 10 are evenly squeezed
between strip 6 (V2 ) and 11 (V5 ). Strips 2 and 3 are located at the junction of
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Figure 3.1: (A) Overview of ECG imaging workflow, (B) examples of ECG
pre-processing using custom research software, which allows adjustment of
filtering parameters through sliding bars, drop-downmenus, and text boxes.
.

the middle and outer third and at the junction of the inner and middle thirds
of the clavicle, respectively. Strip 16 is located directly over the dorsal spine.
Strips 17 and 18 are located directly posterior to these two columns, with the
same landmarks used to position columns 14 and 15 on the left side.
Using custom research software (ECG viewer, Rochester Institute of Technology, Rochester, NY), noises in 120-lead ECGs are removed using wavelet
filters: while filtering parameters are adjustable through the software interface,
a level-8 decomposition is most commonly used with a symlet-8 wavelet. To
correct baseline drift, a polynomial of degree 6–10 fit to and then subtracted
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Figure 3.2: Electrode sites on the body surface [5].

from the ECG waveform. The process of de-nosing and baseline correction is
illustrated in F igure 3.1.2B. Finally, faulty leads are discarded and representative QRST complexes are selected for ECGi.

3.2.2

Geometry Modeling

To construct the bi-ventricular model, as illustrated in F igure 3.3, manual segmentation is performed on a stack of short-axis MRI or CT images to extract
the contour of each ventricular surface (left endocardium, right endocardium,
and epicardium). The segmented binary images of surface contours are then
combined to create a triangulated surface mesh of the ventricles using the
iso2mesh library [51]. This segmentation and meshing process are carried out
using a custom MATLAB routine.
To construct the body-surface mesh, we aim at extracting the 120 surface
electrodes from the thorax CT or MRI images. As illustrated in Figure 3.3,
this is performed using the 3D slicer software [52] that allows us to view
the stack of 2D axial scans in 3D with surface electrode visible on the body
surface. Locations of visible electrodes are manually selected, while locations
of non-visible electrodes are approximated from neighboring visible electrodes
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Figure 3.3: Illustration of the image-based generation of subject-specific biventricular and thorax models.

based on the pre-defined Dalhousie 120-lead mapping protocol [48]. This is
a reasonable approximation because the 120-lead electrodes are placed in 18
strips with fixed inter-electrode distance. The coordinates of all electrodes
are then used to construct a triangulated surface mesh using the iso2mesh
package [51].

3.2.3

Forward and Inverse Process

The ventricular and torso mesh of each subject is input to the open source
SCIRun toolkit [39] to obtain the forward operator that relates extracellular
potential φv (t) at ventricular epicardial and endocardial surfaces to bodysurface potential φb (t), as described in Equation (3.7). φv (t) is then reconstructed from φb (t), pre-processed as describe in Section 3.2.1, by solving
the second-order Tikhonov regularization explained in Equation (3.8) using a
custom Matlab routine.
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Related Works: ECGi of VT

ECGi has the potential to overcome all challenges that come with catheter
mapping techniques because of its noninvasive nature. It can be safely performed prior to a procedure for treatment planning. It can rapidly map arrhythmia episodes that are too short-lived for contact mapping. Furthermore,
it can allow mapping multiple surfaces at the same time. However, ECGi in
scar-related VT has been studied very well, where are a few research papers
were published on this topic.
For mapping VT substrates, there were two clinical studies [16] [17]. In
both studies, ECG signals were recorded from the body surface of each patient,
along with the CT for the heart and the torso to build patient-specific geometry. Both studies have shown that ECGi is able to delineate myocardium scar
and the findings were consistent with the invasive catheter mapping.
For mapping VT circuits, investigations included five studies of the VT
circuits. Two of them were animal studies [18] [19] and the other three were
human studies [20] [21] [22]. In the animal studies, post-infarction canine
hearts were placed inside a torso tank and the myocardial infarctions were
surgically created by using the two legations model. This type of surgery has
been preferred by many researchers due to their ability to control the size of
myocardial infarctions by ligating the left anterior descending coronary artery
(LAD) first and then trying to ligate one or more additional distant branches
to prevent collateral flow and at the same time, if the animal can tolerate
that, they can remove the legation immediately. The electrogram signals were
recorded on the surface of the epicardium during VT using a 490-suck electrode during an open chest. These signals were used to generate the body
surface potentials (BSP) on a human torso, where Realistic geometry errors
and measurement noise were added to the torso data. For the first study [18],
the BSP data were used to reconstruct signals on the epicardium surface to
be used later to identify the central common pathway, the VT exit site, lines
of a block, and regions of slow and fast conduction inside the scarred region.
They showed that the ECGi can identify and localize key components of the
arrhythmogenic pathway that can be effective targets for antiarrhythmic intervention during VT. In the second study [19], they used the same method
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that was used in the first study with a few changes. The sinus rhythm data
was collected along with VT data from the epicardium surface of the dogs’
hearts. After the ECGi signals were reconstructed on the epicardium surface
(using the same method used in the first study) of the two hearts, the ECGi
results were evaluated by direct comparison to measured data. Reconstructions were performed during right atrial pacing and nine cycles of VT. The
results showed that the ECGi was able to localize the abnormal infarct substrate, localize epicardial breakthrough sites, and evidence for activation of
the Purkinje system and septum during the reentrant beats.
In the human studies [20] [21] [22], ECG signals were recorded and the
patient-specific geometries were built for each patient. In the first study [20],
the ECGi was evaluated in four patients who underwent VT ablation. The
120-lead body surface potential data were collected during implantable defibrillator pacing, catheter pacing data from epicardial sites and VT data were
recorded, and epicardial patient-specific heart-torso models were extracted
from computed tomography (CT) images. The findings of this paper were
compared to invasive voltage mapping, where it showed that the ECGi maps
can identify sites of epicardial pacing, epicardial VT exit sites, and ventricular
activation sequences with good accuracy. In [21], 250-lead body surface potential data were collected during sustained VT, and epicardial patient-specific
heart-torso geometries were extracted from detailed computerized axial tomography (CAT) scans. The ECGi was applied to patients who underwent
catheter ablation for VTs. The findings revealed a large diversity of human VT
with respect to activation patterns, mechanisms, and sites of initiation. The
ECGi results were consistent with those of invasive catheter mapping. In [22],
ECGi was used to guide the radioablation therapy, five patients participated
in the study. The goal of the study was to combine ECGi and noninvasive cardiac radioablation for ventricular tachycardia to perform catheter-free therapy.
The VT was induced using an implantable cardioverter defibrillator (ICD).
The ECGi was able to identify the myocardial scar and the arrhythmogenic
region from which ventricular arrhythmias arise. Then the noninvasive cardiac
radioablation was applied. All the patients showed a significant reduction in
the number of VT episodes.
In summary, electrocardiographic imaging beyond the epicardial mapping
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of scar-related VT is very limited, where all the studies mentioned above
focused only on delineating myocardial scar in post-infarction hearts without
addressing the surviving tissue features, such as the fractionation signals, or
studying the reentrant circuits of the VT on only one surface (epicardium),
which may not be enough to identify the ablation targets. Moreover, none of
them tried to add other modalities, such as MRI to the ECGi to help improve
the accuracy of the ECGi mapping. In this dissertation, we will investigate
if 1) extending ECGi from epicardial mapping to simultaneous epicardial and
endocardial mapping and 2) combining ECGi with MRI scar analysis would
improve identify locations and morphologies of the VT circuits during sinus
rhythm and VT.

Chapter 4

Non-invasive Epicardial and
Endocardial Imaging
4.1

Introduction

As detailed in chp:Basics earlier, catheter mapping has the following critical
challenges for mapping scar-related VT due to its invasive nature: First, it
does not allow non-invasive planning prior to the ablation procedure. Second,
it does not allow rapid mapping of the vast majority of reentrant VT circuits
that are short-lived due to multiple morphologies, non-sustained arrhythmias,
and haemodynamic instability. Finally, invasive mapping is most often done
at one surface at a time, while simultaneous epicardial and endocardial mapping is technically challenging and not routinely available at all centers.
In this Chapter, we investigate the use of simultaneous epicardial and
endocardial ECGi (epi-endo ECGi) for substrate and activation mapping of
scar-related VT. In specific, we focus on the feasibility of: 1) extracting sites
of signal fractionation suggesting critical sites for VT circuits using ECGi substrate mapping during sinus rhythm, and 2) using phase mapping for on overall
activation pattern of re-entry circuits using ECGi during brief episodes of induced VT. In both tasks, we also compare epi-endo ECGi to epicardial-ECGi.
Our hypotheses are: 1) during native rhythm, ECGi can reveal not only regions of the myocardial scar but also local abnormal electrograms indicative of
potential critical sites for VT, 2) ECGi can map unstable VT re-entry circuits,
23
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and 3) epi-endo ECGi can improve the delineation of 3D re-entry circuits and
their arrhythmogenic substrates compared to epicardial-ECGi. Experiments
were performed on a small case series of four patients who underwent catheter
ablation of scar-related VT [20]. ECGi results were evaluated by in-vivo contact mapping data and VT exits localized from successful ablation procedures.

4.2

Materials and Data

Four consecutive consenting patients undergoing epicardial and/or endocardial catheter mapping and ablation of VT were enrolled. In a protocol approved by the institutional Research Ethics Board, patients underwent axial
computed tomography (CT) imaging within 24h before the procedure. Immediately before the ablation procedure, body surface electrodes were applied
and a 120-lead ECG were recorded with a 2000-Hz sampling rate during (i)
sinus or implantable cardioverter-defibrillator (ICD) paced rhythm and (ii)
induced clinical VT. These data provide the input for ECGi.
Catheter mapping and ablation were performed according to usual clinical
protocols. Left ventricular endocardial mapping was performed by the retrograde aortic approach. The pericardial space was entered percutaneously using
previously published techniques. A 3D electroanatomic mapping system was
utilized to acquire substrate maps during sinus or ICD-paced rhythm. Ventricular tachycardia was induced by programmed stimulation from the right
ventricular apex or outflow tract. When VT was inducible and tolerated, the
site of VT exit was identified via a combination of activation and entrainment
mapping. When VT was not inducible, non-sustained, or haemodynamically
unstable, the potential site of VT exit was identified using a 12/12 pace-match
during pace-mapping. At the end of the procedure, the non-inducibility of the
clinical VT was confirmed using a standard programmed stimulation protocol with up to triple-extra stimuli. These data, specifically electroanatomical
mapping of the scar substrate and the location of VT exits determined during
the ablation procedure, provide evaluation data for ECGi.
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4.3

Methods

In specific, to reduce the ill-posedness of the inverse problem, the resolution of
the biventricular mesh was kept at a moderate level of 7.75 ± 2.20 mm with
198 ± 40 nodes on the epicardium and 258 ± 42 nodes on the endocardium.
The torso was modeled as a homogeneous triangulated surface mesh, with 120
nodes representing surface electrodes at a resolution of 39.34 ± 10.12 mm.
For comparison purposes, epicardial-ECGi was performed on epicardial
ventricular models independently obtained from each patient in previously
published work [20]. The rest of the ECGi pipeline was kept identical in
the comparison study to isolate the effect of including endocardial surfaces in
ECGi.

4.3.1

Substrate Mapping and Quantitative Evaluation

From ECGi computed electrograms (CEGMs) during native rhythm, sites of
scar were identified based on the presence of wide or large Q waves (>0.04
seconds in duration or deeper than one-fourth of the amplitude of the following R wave) and small R wave amplitude as described in [18]. Fractionated
signals were identified as those with low R amplitude and QRS-complexes that
comprise more than two positive deflections.
ECGi-identified scar was quantitatively evaluated against electroanatomic
bipolar voltage map where bipolar voltage represented the difference between
the maximum and minimum magnitude of a bipolar electrogram: myocardial scar core was identified with bipolar voltage <0.5mV and scare border
with the bipolar voltage between 0.5 and 1.5mV. These electroanatomic maps
were post-operatively registered to CT-derived ventricular meshes using a rigid
transformation based on visual inspection of anatomical landmarks, followed
by a nonrigid registration method known as coherent point drift [41]. On each
heart, the size of the identified scar and fractionated CEGMs were calculated.
The overlap of ECGi-identified scar with the electroanatomic low-voltage scar
was evaluated using three metrics: DICE= 2TP/(2TP+FP+FN), sensitivity=
TP/(TP+FN), and specificity= TN/(TN+FP), where TP, FP, TN, and FN
denote the region of true-positives, false-positives, true negatives, and falsepositives in ECGi scar identification compared with electroanatomic maps. In
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addition, to study the association of CEGM and electroanatomic data, the
following features were extracted from each CEGM: the voltage was defined
as the difference between the maximum and minimum magnitude of a CEGM
signal, and duration was measured from the onset to the end of the CEGM
deflections. Linear regression was used to model the association between electroanatomic bipolar voltage as the dependent variable, and CEGM voltage and
duration as the independent variables. Instead of using a fixed-effect model
on data pooled across the three subjects, we considered potential inter-subject
differences and utilized a mixed-effect model to group the data by each individual subject [53]. Therefore, the model has shared fixed effects across the
subjects and has random-effects accounting for individual-level differences.

4.3.2

Ventricular Tachycardia Mapping

Phase mapping has been used to track the spatiotemporal progression of atrial
and ventricular arrhythmias [54]. However, the quantitative relation between
phase- and EGM-determined activation sequences remains unclear, which will
be examined in this study. To determine activation sequence from CEGM
signals, we utilized a previously published method [55] that considered the
maximum negative gradient in temporal CEGM signals weighted by the spatial gradient. To calculate instantaneous phase signals from CEGM signals,
because the CEGM during monomorphic VT showed a clear periodic pattern,
the Hilbert Transform (HT) was directly applied to the CEGM after removal
of the mean from the signal; instantaneous phase signal at each spatial location was then calculated from each CEGM signal and its time-shifted version
resulting from the HT, as described in [54]. The time of activation is determined at the time of phase= π/2 as suggested by a recent study [56].
The results were qualitatively evaluated due to the lack of quantitative
reference data. The earliest activation site in the reconstructed circuit was
visually compared to the general anatomical location of the VT exit identified
from the ablation procedure. The morphology of the reconstructed circuit was
analyzed with respect to the location of the electroanatomic map scar.

CHAPTER 4. NON-INVASIVE EPICARDIAL AND ENDOCARDIAL IMAGING27

4.4
4.4.1

Results
Substrate Mapping

ECGi was performed during sinus rhythm in patients 1 and 2, and during ICDpaced rhythm in patient 3. Patient 4 was removed from this analysis because
excessive noise in ECG data precluded analysis of low amplitude CEGMs.
Comparison to in-vivo voltage data and epicardial ECGi
F igure 4.1 compares side-by-side the scar obtained by epi-endo ECGi, epicardialECGi, and electroanatomic voltage maps registered to the CT-derived biventricular mesh on each patient. In terms of scar identification, both ECGi
methods were consistent with electroanatomic voltage data in the general location of the myocardial scar, although the quantitative overlap between ECGi
and electroanatomic scars was limited. This was especially true when the scar
distribution was heterogeneous and extensive, such as in patient 3, where both
ECGi methods appeared to overestimate the region of inferior scar whereas
the epicardial-ECGi solution also under-estimated the heterogeneous lateral
scar. On the epicardial level, it appeared that the two ECGi solutions were
more similar to each other than to electroanatomic data. On the endocardial level, epi-endo ECGi was able to reveal the presence (patient 1 and 3)
and absence (patient 2) of endocardial scar: in patient 1, the location of the
endocardial scar was consistent with electroanatomic data; while endocardial
electroanatomic data were not available in patients 2 and 3, the presence of
endocardial scar was expected in patient 3 since a mid-septum endocardial
VT exit site was found during the ablation.
In terms of sites of signal fractionation, epi-endo ECGi identified a a small
number of fractionated signals inside the scar in each patient (denoted by
white dots in F igure 2). In patients 1 and 2, two clusters of fractionated sits
were found: one cluster was located at the heterogeneous region of the electroanatomic map scar near the location where a VT exit was identified during
ablation (the approximate location of the exit was labeled by a white scar in
all cases); the other cluster was located at the margin of the electroanatomic
map scar. In patient 3, where the scar was the most heterogeneous, more
fractionated signals were found at the heterogeneous region and margin of the
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Figure 4.1: Substrate mapping using ECGi. (A1/B1/C1) Comparison of electroanatomic bipolar voltage maps (row 1), epi-endo ECGi scar (row 2), and
epicardial ECGi scar (row 3). Colour maps for electroanatomic map data encode the bipolar voltage with a cut-off of >1.5 mV for healthy tissue (blue)
and <0.5 mV for scar core (red). Colour maps for ECGi data encode the label
of ECGi-identified tissue where blue represents healthy tissue, red represents
scar, and yellow represents sites of fractionation. Sites of signal fractionation
were also highlighted using white dots and superimposed with electroanatomic
and epi-endo ECGi scar maps. (A2/B2/C3) Examples of ECGi-computed electrograms. In each electrogram plot, the x-axis represents time in ms and the
y-axis represents the amplitude of the signal in mV. ECGi; LV lateral, left
ventricular lateral.
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Figure 4.2: Top: quantitative metrics of ECGi-identified scar in comparison to
electroanatomic map low-voltage scar. Bottom: CEGM voltage, duration, and
voltage/duration ratio at healthy myocardium and sites of signal fractionation.
CEGM, computed electrogram; ECGi.

electroanatomic map scar. One site of signal fractionation was also found on
the endocardium of this patient, although it was localized on the basal-anterior
region while the VT exit was found on the mid-septum of the left ventricle
(LV). Examples of CEGMs reconstructed by ECGi are illustrated in F igure
4.1 for each patient.
Quantitative and statistical analysis
An average of 493 ± 18 CEGMs were analyzed for each patient. Identified
region of the scar had an average area of 129 ± 20 cm2 and 25 ± 4% of the
overall ventricular surface. Identified sites of signal fractionation had an average area of 13 ± 7 cm2 and 2 ± 1% of the ventricular surface. F igure 4.2
summarizes the quantitative metrics of ECGi-detected scar in comparison to
electroanatomic data, as well as the average CEGM voltage, duration, and
voltage/duration ratio in healthy and fractionated sites for each patient. The
final linear mixed-effects model showed that CEGM voltage (β = 0.16 mV/mV,
P = 0.03) and duration (β = 0.19 mV/ms, P = 0.01) were significantly associated with electroanatomic bipolar voltage, where β is the coefficient associated
with the respective independent variable in the regression model.
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Figure 4.3: Comparison of activation sequence extracted from phase signals
and electrogram signals, (A) activation time map extracted from phase signals
at the time of phase= π/2, (B) activation time map extracted from electrogram
signals. Both color maps in A and B encode the value of activation time, (C)
selected electrogram signals (blue) and phase signals (red) at locations as
annotated in (A and B). Blue and red dots indicate the time of activation
determined, respectively, from the time of steepest downslope on electrogram
signals and from the time of instantaneous phase= π/2 on phase signals. In
each plot, the x-axis represents time in ms. Two y-axes are used. The left
y-axis (for phase signal) represents the value of the phase. The right y-axis
(for electrogram signal) represents the amplitude of the signal in mV. EGM,
electrogram.
.

4.4.2

Ventricular Tachycardia Mapping

During induced VT, ECGi reconstructed five re-entry circuits among the four
patients.
Activation sequence from phase vs. computed electrograms
F igure 4.3A and B compare an activation sequence determined from CEGM
and phase signals. F igure 4.3C provides examples of local CEGM (blue) and
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phase (red) signals selected in their order of activation from this sequence: on
each signal, the corresponding time of activation is marked by a dot with a
vertical bar. As shown, while the CEGM-derived time of activation closely
approximated the time of 0.5π in phase signals at some locations (examples
2 and 5), the discrepancy was larger at other locations (examples 1, 3, and
4). The general order of activation, however, was concordant between CEGM
and phase-derived activation sequences as noted by the black arrow in F igure
4.3. The resulting maps of activation thus showed a qualitatively similar
conduction pattern in the form of a counter clock-wise rotation on the lateral
wall of the LV with similar locations of the earliest activation. There, however,
existed a quantitative discrepancy. This observation was consistent among
all five VT circuits being studied. Across the five VT circuits analyzed, the
difference between CEGM derived activation time and that derived from phase
= 0.5π was 21.06 ± 28.33 ms, and the value of phase at the time of CEGM
derived activation was 0.44π ± 0.16π.
Comparison with epicardial ECGi
F igure 4.4 summarizes activation maps of all five circuits obtained from phase
mapping using epi-endo ECGi (row 1) vs. epicardial-ECGi (row 2): the first
view was selected to best represent the overall morphology of the circuit obtained by epi-endo ECGi, followed by standard anterior and inferior epicardial
views to facilitate comparison with epicardial-ECGi.
In VT1, both methods revealed an epicardial exit at the basal lateral region
of the LV, along with a counter-clockwise rotation anchored at the epicardium
of the left ventricular lateral wall. This estimated location of exit was consistent with that determined by the ablation procedure.
In VT2 and VT4, epi-endo ECGi revealed re-entrant circuits that exited,
respectively, at high basal-inferior epicardium and the basal inferolateral region of the left ventricular endocardium. Both locations were consistent with
those determined from the ablation procedure. Activation maps obtained by
epicardial-ECGi were similar to those obtained by epi-endo ECGi on the epicardium. Without the endocardial view, however, an epicardial exit would
be suggested in both cases, with the exit in VT5 corresponding to the site of
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Figure 4.4: Five VT activation maps obtained by epi-endo ECGi (row 1 in
each panel), in comparison to those obtained by epicardial-ECGi (row 2 in each
panel). Color maps encode the value of activation time. VT exits determined
from ablation procedures are noted in the left bottom panel of the figure.
VT exits determined from ECGi are labeled by white stars. Each circuit is
represented in three views: the first represents the best view to summarize the
morphology of the epi-endo ECGi circuit, followed by standard anterior and
inferior views to facilitate comparison with epicardial- ECGi. VT, ventricular
tachycardia.

epicardial breakthrough from the endocardial exit. In both cases, the absence
of an endocardial view also suggested a focal rather than reentrant mechanism
(indicated by the white arrows).
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In VT3 and VT5, epi-endo ECGi revealed re-entrant circuit exiting, respectively, at the mid-septum and basal anterior region of the left endocardium,
consistent with the general anatomical regions determined from the ablation
procedure. Epicardial activation patterns obtained by epicardial-ECGi again
resembled those from epi-endo ECGi. Using epicardial views only, however,
an epicardial anterior basal exit would be suggested in both cases, reflecting the epicardial breakthrough from two different endocardial exits. While
the epicardial activation pattern suggested a focal mechanism, interestingly,
a ‘projection’ of the endocardial activity generated from epi-endo ECGi appeared to be obtained on the basal view of epicardial-ECGi an artificial surface
closing the atrioventricular plane.
Examples of detailed phase map sequence of VT1 and VT5 obtained by
epi-endo ECGi are provided in F igure 4.5 Of note, in VT1, a slowing of
conduction (crowding of isochrones) was observed along the boundary of the
electroanatomic map scar at the left ventricular lateral wall, and a a zig-zag
course of propagation and very-slow conduction was observed inside the scar.
In VT5, the conduction was fast at the lateral and inferior epicardium where
there was minimal evidence of scar on electroanatomic mapping, whereas the
conduction was slow at basal anterior epicardium where there was a large
electro anatomically mapped scar. These examples show, qualitatively, the
relationship between ECGi-reconstructed circuit morphology and the underlying scar substrates.

4.5

Conclusions and Discussion

This study demonstrated the feasibility of simultaneous epi-endo ECGi for
mapping scar substrates and re-entry circuits in scar-related VT. For substrate mapping, ECGi reasonably agreed with electroanatomic mapping data
but the overlap was quantitatively limited. This suggested that the true potential of ECGi, rather than in electrically delineating myocardial scar may
lie in the identification of local abnormal electrograms suggestive of critical
sites for VT. While this small case series provided initial examples where
ECGi-detected sites of signal, fractionation was located near a VT exit or heterogeneous scar margin, further studies are required to establish this finding in
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Figure 4.5: Examples of phase map sequence from ECGi of two re-entry circuits. The depolarization wavefront is tracked by white arrows (at phase =
π/2) to facilitate visualization. The timing of each snapshot with respect to
the onset of surface QRS is labeled and tracked on the ECG trace of lead
V2 (i.e. -20ms = 20ms before the QRS onset). Electroanatomic map scar
is shown as a light-grey patch. (A) VT1 of patient 1: a counter-clockwise
macro-reentry centered at the inferior lateral region of the epicardium, with
an epicardial exit at the basal inferolateral epicardium. (B) VT5 of patient 4:
a macro re-entry, with an exit at the basal-anterior endocardium.
.
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a larger sample size as well as to determine whether ECGi could reveal additional low-amplitude characteristics such as isolated potentials and other local
abnormal activities. For VT mapping, this study showed that the earliest sites
of activation determined by epi-endo ECGi were qualitatively consistent with
the anatomical region of the VT exits determined from the clinical procedure,
including both epicardial and endocardial exits. Without an endocardial view,
the earliest site of activation from epicardial-ECGi may reflect the epicardial
breakthrough from the endocardial exit. In addition, while epi-endo ECGi revealed macro-reentry in all five cases, epicardial-ECGi in some cases revealed
a focal rather than re-entrant mechanism, and in other cases indicated a reentrant circuit in the artificial surface closing the atrioventricular plane that
resembled a projection of the endocardial activity reconstructed by epi-endo
ECGi.
Generally, phase signals reflected the relative order of activation in space.
If local CEGM morphologies were similar across the space, the phase-generated
time of activation would be similar to those generated by CEGM with a constant time shift. However, since the actual CEGMs differed substantially in
morphology over space, there was no clear theoretical or experimental evidence supporting the existence of an exact phase value at which the time
would correspond to CEGM-derived time of activation. Our results showed
that the general order of spatial activation was qualitatively concordant between CEGM- and phase-derived activation, indicating that phase mapping
may be suitable for supporting the analysis of the general morphology of an
activation circuit. For quantitative analysis, the use of phase mapping warrants further investigations.
Human validation of ECGi in scar-related VT remains a significant challenge. In previous work, focal VT was studied in healthy rabbit [57] and canine
models [58] without structural diseases; in the setting of scar-related VT, case
studies of animal models were reported utilizing animal hearts placed in a
torso tank [18] [59]. In the limited existing human studies [20] [21] epicardial
mapping of re-entry circuits was evaluated qualitatively to contact mapping
data similar to this study. This study extended the work by Sapp et al [20]
on the same patients to ECGi study of the endocardium. Similar to previous
studies [20] [21] this study was limited in the validation data and could be
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improved by activation/entrainment mapping data of stable VT or 3D DGEMRI data of myocardial scar. This requires substantial effort in experimental
design and data collection, although case studies have emerged to utilize joint
DCE-MRI and catheter mapping to evaluate ECGi in scar-related VT.
Several factors may affect the analysis of ECGi and its use in clinical practice. First, the challenge of intra-operative registration between MRI/CT and
electroanatomic maps have to be tackled in order to merge ECGi maps into
the catheter mapping space. Second, as a feasibility study of epi-endo ECGi in
scar-related VT, the classic Tikhonov regularization was used for the inverse
reconstruction of the ventricular electrograms. This method can be affected
by the choice of the regularization parameter as discussed in previous work Future studies should consider alternative inverse methods that are more robust
to regularization parameters. Finally, the presented ventricular model did not
include the right ventricular outflow tract (RVOT) that is less frequently relevant in scar-related VT. The effect of excluding the RVOT in ECGi should
be investigated in future studies.

Chapter 5

Characterizing 3D Reentrant
Ventricular Tachycardia
5.1

Introduction

Now that we demonstrated the feasibility and accuracy of epi-endo ECGi in
mapping the surface solutions, we proceed to investigate the possibility of
inferring information about the 3D circuits using these surfaces information.
Current analyses of the morphology of reentrant circuits primarily rely on
catheter mapping on the surface of the ventricles (epicardium and/or endocardium), providing a two-dimensional (2D) view of the reentrant circuit of
assuming all of its critical components are confined to one of the heart surfaces (F igure 5.1A). This, unfortunately, oversimplifies the spatiotemporal
construct of reentrant circuits, which is 3D in nature and can involve the
mid-myocardium wall (F igure 5.1B). A recent study [13] showed that simultaneous epicardial and endocardial (epi-endo) mapping, instead of mapping
only epicardial or endocardial activation, can facilitate inferences about midmyocardial activation of 3D reentrant circuits.
However, such high-resolution and simultaneous epi-endo catheter mapping is difficult to obtain in clinical practice. A noninvasive approach for
rapid simultaneous epi-endo mapping, such as ECGi, may have promise for
facilitating inferences about the 3D characteristics and mid-wall involvements
of VT circuits.
37
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Figure 5.1: Illustration of a 2D portrait of a ventricular reentrant circuit, (A)
a 2D circuit on one surface, (B) a 3D circuit where two surfaces and mid-wall
is involved.

To our knowledge, however, the potential of ECGi for delineating the 3D
characteristics and mid-wall involvement of reentrant circuits has never been
investigated, nor is its ability to delineate detailed critical circuit components
beyond localizing circuit exits.
In this dissertation, we present the first study of the use of epi-endo ECGi
to enable 3D analyses of reentrant circuits in scar-related VTs. First, following the approach described in [13] for analyzing simultaneous epi-endo
catheter mapping data, we perform a systematic isochronal analysis of ECGireconstructed electrocardiograms on both the epicardial and endocardial surface. Based on the percentage of activation seen on each surface during
the cycle length (CL) of a VT, we categorize the reentrant circuits into 2D,
3D transmurally uniform, 3D transmurally non-uniform, and mid-myocardial
propagation following the definitions in [13]. Second, noting that ECGi tends
to reconstruct reentrant circuits as rotating waves with time-varying anchoring
points, we track the time-changing trajectory of these anchors during VT and
study their relationship with the critical components of the reentrant circuits.
Finally, we identify the activation (breakthrough) on epi and endocardium surfaces. Then we calculate the distance between the actual VT exit and the two
breakthroughs and the time between the epi and endocardium breakthroughs
for both simulation and ECGi data for all the cases. We find a strong relationship between the calculated distances and times, which can help infer the
location of the VT exit even when it is inside the wall.
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Because of the difficulty to obtain detailed VT morphologies in an invivo setting simultaneously with high-density surface ECG, we leverage highfidelity simulation data of reentrant circuits generated on post-infarction animal models [60] in this proof-of-concept study. This allows 3D assessments of
reentrant circuits on the simulated data as detailed ground truth for evaluation
of ECGi results. Experimental results showed that ECGi characterizations of
3D reentrant circuits were consistent with the ground truth in 83% of the
cases, facing difficulties in two endocardial circuits, one transmurally nonuniform circuit, and one mid-wall circuit. These results provide a proof of concept
that epi-endo ECGi, with its nature of noninvasive and rapid mapping, may
facilitate inferences about mid-myocardial activation of reentrant circuits to
guide targeted detailed catheter mapping.

5.2

Materials and Data

It is challenging to obtain detailed reference data for local circuit dynamics
and central isthmus of in-vivo reentrant circuits, especially in conjunction with
high-density surface ECG data to support ECGi. In comparison, reentrant circuits virtually induced on detailed ventricular model with high-resolution scar
morphology have been shown to provide important information into the morphology of reentrant circuits [60]. To provide detailed ground truth of the
critical components and 3D characteristics of the reentrant circuits for a thorough assessment of ECGi, in this study, we considered ECGi reconstruction
of 23 scar-related reentrant circuits simulated on eight chronically infarcted
porcine hearts.

5.2.1

Simulation-based Animal Model Study

The eight chronically infarcted porcine hearts were acquired in a previous
study in accordance with the Johns Hopkins University Institutional Animal
Care and Use Committee [60,61]. On these animals, in-vivo LGE images were
obtained using a T1-weighted gradient-echo sequence with the following scan
parameters: acquired resolution = 0.25 × 0.25 × 0.50 mm; reconstructed voxel
size = 0.25 × 0.25 × 0.25 mm; echo time = 2.3 ms; repetition time = 12 ms;
flip angle = 15º; and scan duration = 1 hour. Diffusion tensor (DT) MRI was
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performed in the same hearts using a customized 3D spin echo sequence [62].
The acquired and reconstructed voxel dimensions for the diffusion images were
0.6 × 0.6 × 1.2 and 0.4 mm, respectively, and the total scan duration was 42
hours per heart. Detailed methodology, including data acquisition and sample
preparation, can be found in previous publications [60, 61].
Detailed models of the intact large animal ventricles were constructed from
these in-vivo data, with image-based fiber orientation and detailed scar geometry obtained at a voxel size of 0.03125 mm3. Electrical wave propagation was
modeled by the monodomain formulation, and the simulations were performed
using the software package CARP (CardioSolv, LLC) on a parallel computing platform as detailed in previous publications [60, 63]. Monomorphic VTs
were induced in all the hearts using a clinical S1-S2-S3 programmed electrical
stimulation protocol [64], applied from 27 pacing sites selected on the basis
of a modified American Heart Association segment designation. A total of
23 sustained VTs (lasting for at least 2s after the last pacing stimulus) were
induced. For each reentrant circuit, its pathway in the form of a string loop
was identified by connecting seed points along the fastest part of its 3D route.
To simulate the body-surface ECG corresponding to each reentrant circuit,
each animal heart was placed in a human torso model in the form of a triangular mesh with 120 vertices representing 120 surface ECG leads. The forward
operator specific to each heart-torso pair was constructed using the SCIRun
software [65]. Epi-endo extracellular potential was simulated from each reentrant circuit solving the Poisson’s equation underlying the quasi-static electromagnetism using a custom software [66], which serves as the cardiac source
model in the ECGi formulation considered in this study and used to generate
the 120-lead body-surface ECG using the forward operator. The surface ECG
was added with 20-dB Gaussian noise and input for ECGi reconstruction of
epi-endo extracellular potential.

5.2.2

Data Processing

We processed the simulated reentrant circuits to obtain the reference data for
evaluating ECGi results: the 3D categorization of the reentrant circuits, and
the localization of their critical components including the entrances, exits, and
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central isthmuses. First, each reentrant circuit was classified into one of the
four categories based on the method and definition as described in Section
5.3.1. Second, to localize the critical components of each reentrant circuit,
we track the temporal dynamics of the activation wavefront within each VT
cycle. We noted that the circuit wavefront showed a substantial traveling
inside vs. outside the myocardial scar: when outside (F igure 5.3.A1-A6),
the activation wavefront exhibited a continuous spatiotemporal propagation,
involving a relatively larger portion of the myocardium with an anchor moving
locally around the scar core; when inside (F igure 5.3.B1-B6), the activation
wavefront was local and isolated, advancing in a zigzagging trajectory within
the scar. We followed this observation to manually define the exit, entrance,
and central isthmus of each simulated reentrant circuit.

5.3

Methods

The ECGi in this part of the dissertation was constructed using simulated
body surface data as described in chp:Foundation.

5.3.1

3D Characterization of the Reentrant Circuits

It can be complicated to categorize the activation pattern for a VT reentrant
circuit that can involve more than one surface (F igure 5.1B). Following the
method described in [13], instead of assuming that the complete reentrant circuit lives on one epicardial or endocardial surface, we simultaneously quantify
the activation pattern on both epicardial and endocardial surfaces and use
their temporal relation to infer the mid-myocardial involvement of the reentrant circuits. Specifically, we: 1) generate isochronal maps on both surfaces,
2) examine the percentage of activation within a full cycle of the reentrant circuit on each surface, and 3) combine the view on both surfaces to determine
the 2D or 3D category of the VT circuit.
To extract activation isochronal maps, we first apply the Hilbert transform
to heart-surface electrocardiograms to obtain the phase signal at each spatial
location as described in [54]. The activation wavefront at any time instant
is then determined as the location with phase =π/2 as suggested by [56, 67].
Following the work in [13], a fixed number of eight isochrones are extracted.
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Figure 5.2: Examples of isochrones maps of different types of 3D circuits, (A)
3D transmurally non-uniform circuits with complete rotation seen on the epicardium, and partial rotation with activation gap seen on the endocardium,
(B) 2D circuits with complete rotation seen on the endocardium, and focal
propagation on the epicardium, (C) 3D transmurally non-uniform circuits with
partial rotation with activation gap seen on the endocardium, and focal propagation on the epicardium, (D) Mid-myocardial circuit with focal propagation
seen on both surfaces.

From the isochronal maps, we locate reentrant circuits as the region where
rotations of activation can be seen, and identify the portion of activation
within the full cycle of VT that is visible on each surface. The activation
gap, as defined in [13], is the period of time when activation of the reentrant
circuit is missing from a surface and is marked by missing color (black color)
in the isochronal color bar as shown in (F igure 5.2). If a rotation is not at
least partially visible on a surface, the activation is considered focal on that
surface (F igure 5.2D1). Finally, we combine the isochronal maps on the two
surfaces to categorize the 3D characteristics of reentrant circuits following the
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definition used in [13]:
• 2D circuits: A complete rotation without any activation gap (all isochronal
colors) is seen on one surface and focal activation is seen on the other
surface. An example is shown in F igure 5.2B.
• 3D non-uniform circuits: Partial rotations with activation gaps are observed on both surfaces, or partial rotation with activation gaps is observed on one surface and focal activation on the other. Examples are
shown in F igure 5.2A and F igure 5.2C.
• 3D uniform circuits: Complete rotations without activation gaps are
observed on both surfaces.
• Mid-myocardial circuits: Focal activation is observed on both surfaces,
suggesting that the reentrant circuit happens in the myocardial wall. An
example is shown in F igure 5.2D.

5.3.2

Localization of the Reentrant Circuits

After characterizing the 3D category of a reentrant circuit, we proceed to localize the portion of the circuit visible on each heart surface. As illustrated in
F igure 5.3A, a reentrant circuit is expected to exhibit isolated local activation within the critical isthmus (F igure 5.3. A7-A12). We observed that, by
solving equation (3.8), the obtained ECGi solutions, in general, are not able
to resolve such local activities but rather exhibit a rotation with an anchor
moving around the scar tissue (F igure 5.3. B7-B12). This inability to resolve
small isolated activity within the critical isthmus can be expected as a natural
outcome of the ECGi formulation considered in this study: 1) it focuses on
global activation pattern and may miss small local activation pattern buried
within the global ECG signals, and 2) it does not incorporate any other local
structural information, such as the 3D scar tissue, to generate the conduction
block that can protect the activity in the critical isthmus.
We thus proceed to track the anchor supporting the rotation during the
VT cycle in order to evaluate its relation with the critical components of the
actual reentrant circuits. To do so, from the spatiotemporal phase maps for
each circuit at each time instant, we identify the spatial location around which
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Figure 5.3: Illustrations of the activation wavefront during reentrant circuits,
(A) a simulated reentrant circuit showing propagation outside the scar tissue
(A1-A6) and isolated local activity once within the critical isthmus (A7-A8),
(B) a representative ECGi reconstruction of the same reentrant circuit, which
shows a general rotation with anchor points moving around the scar, although
the local activity within the critical isthmus is not well resolved (B7-B12).

the phase values form a complete cycle from -π to +π: this is also known as
the phase singularity point [54].
We track the spatial trajectory of these anchor points overtime over the
VT cycle, and evaluate it against the critical isthmus obtained from the actual
reentrant circuits.
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Figure 5.4: Breakthroughs in different cases on different layers, (A) shows the
wall exit and the two breakthroughs on epicardium and endocardium for the
case case in simulation and ECGi data, (B) shows the exit on the endocardium
and the breakthrough on epicardium for same case in simulation data.

Figure 5.5: Wall exit with Epi-Endo breakthroughs.
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5.3.3

Inferring Beneath the Surface

After processing the simulation data, we noticed that the exit of the VT circuits could be on the epicardium, endocardium, and in the wall. The exit
was in the wall for five (21%) cases. In three (13%) cases, the exit was on
the epicardium, and in the rest of the cases, the exit (65%) was on the endocardium. F igure 5.4A1 shows an example of the exit in the wall, and F igure
5.4B1 shows an endocardium exit in simulation data. When we looked into
the ECGi data, we have noticed that the breakthrough can be seen on both
layers as well, but it is not as clear. F igure 5.4A2 and B2 show that the
ECGi breakthroughs were consistent with the simulation data.
These findings have led to more interesting findings by thinking of how
these breakthroughs can help identify the exact location of the VT exits. Let’s
imagine that there is an exit in the middle of the wall, and the wave-front starts
propagating in all directions until it hits the surface at some time, as F igure
5.5 illustrates. That is when the breakthrough can be seen on the surface.
Thus, we believe if we combine the two breakthrough sites on both surfaces,
we may be able to back infer where the exit is inside the wall. To do that,
we make an assumption that if we have an exit anywhere in the heart wall,
the time it takes the wave-front to travel to a surface is a function of the
transmural distance to the surface and the distance along that surface until it
hits the surface– we separated these two distances into two distances because
it is known that the velocity across the wall is much slower than the velocity
along the wall. In another word, we assume the existence of the following
function:
T epi = (d2p /v2 + d1p /v1 )

(5.1)

T endo = (d2e /v2 + d1e /v1 )

(5.2)

∆T = (d2p − d2e )/v2 + (d1p − d1e )/v1

(5.3)
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where: T epi = time of the breakthrough on the epicardium surafce
T endo = time of the breakthrough on the endocardium surafce
d2p
= transmural distance for the epicardium breakthrough
d2e
= transmural distance for the endocardium breakthrough
d1p
= surface distance for the epicardium breakthrough
d1e
= surface distance for the endocardium breakthrough
v2
= transmural speed
v1
= surface speed
∆T
= breakthrough time difference
We will test whether such an equation can be established using both simulation
and ECGi data.

5.4
5.4.1

Results
3D Categorization of Reentrant Circuits

F igure 5.6A summarizes the 3D categorization of the 23 simulated reentrant
circuits. 2D circuits – complete rotation observed on only one surface while
focal activation observed on the other– were observed in 26% of the cases
(n=6) on the endocardium, whereas 3D circuits were found in 74% of the
cases (n=17). 23% (n=4) of these 3D circuits were partially observed on only
one surface, and one of the circuits was mid-myocardial. None of the simulated
reentrant circuits was 3D transmurally uniform. F igure 5.6B summarizes the
3D categorization of the same reentrant circuits based on ECGi results. 22%
of ECGi-reconstructed circuits were 2D endocardial (n=5), and the rest (78%)
were classified as 3D circuits (n=18) 33% of the 3D circuits were partially observed on only one surface (n=6), and two circuits were reconstructed to be
mid-myocardial. None of the ECGi-reconstructed reentrant circuits was 3D
transmurally uniform. The summary statistics of ECGi-reconstructed reentrant circuits were close to the simulated ground truth in terms of their 3D
categorization.
A detailed case-by-case comparison of the 3D categorization of reentrant
circuits between simulated data and ECGi reconstructions is summarized in
F igure 5.7. As shown, ECGi reconstruction correctly preserved the 3D categorization of the reentrant circuits in 82% of the cases (n=19). Out of six
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Figure 5.6: 3D categorization of reentrant circuits, (A) simulated circuits, (B)
ECGi-reconstructed circuits.

Figure 5.7: Case-by-case comparison of ECGi categorization of 3D reentrant
circuits vs. simulated ground truth: ECGi reconstructions preserved the 3D
category of the reentrant circuits in all but four out of the 23 circuits considered.
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Figure 5.8: ECGi categorization of3D circuits, (A) sensitivity and specificity of
ECGi in reconstructing 2D and 3D non-uniform circuits, (B) confusion matrix
of ECGi reconstruction of 2D, 3D non-uniform, and midwall circuits.

simulated 2D reentrant circuits, four (66%) were correctly reconstructed to be
2D by ECGi. Out of the 17 simulated 3D reentrant circuits, 15 (88%) were
correctly reconstructed to be 3D by ECGi. F igure 5.8A summarizes the sensitivity and specificity for the ECGi in reconstructing 2D and 3D non-uniform
cases (we excluded the mid-myocardial and 3D uniform cases out of the calculation because of the small number or absence of examples).
F igure 5.8B summarizes the confusion matrix for ECGi categorization of
3D circuits. In the four incorrectly reconstructed cases, one mid-myocardial
circuit was reconstructed to be 2D endocardial, one endocardial circuit was reconstructed to be mid-myocardial and one was reconstructed to be 3D nonuniform, and one 3D non-uniform circuit was reconstructed to be mid-myocardial.

5.4.2

Localizing VT Circuits Using ECGi

After categorizing the 2D/3D nature of a reentrant circuit, we proceeded to
evaluate the performance of ECGi in localizing the circuit.
A number of studies have reported the ability of ECGi to approximate the
origin or exits of a VT circuit on the epicardium with reasonable accuracy.
Our focus here was to move beyond this and to understand in detail the limit
to which ECGi was able to reconstruct the exit, entrance, and central isthmus
of the simulated circuits.
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Epicardial ECGi results
Throughout the 23 cases, ECGi was able to reconstruct the epicardial activation pattern with reasonable accuracy of spatial correlation coefficients of
0.84 ± 0.06, temporal correlation coefficients 0.63 ± 0.08, and a relative mean
squared errors (RMSE) of 0.31 ± 0.13. The accuracy of localizing the breakthrough sites on the epicardium was 8.52 ± 5.86 mm, which can be further
broken down to 6.96 ± 3.32 mm for 2D endocardial circuits (n=6), and 9.07
± 6.52 mm for 3D circuits (including 3D non-uniform and mid-myocardial
circuits, n = 17).
However, it is important to keep in mind that, because of the 3D nature
of the reentrant circuits, the epicardial breakthrough may or may not be close
to the actual circuit. Below, we present analyses of the clinical relevance of
epicardial ECGi reconstructions depending on the 3D nature of the reentrant
circuits.
3D/endocardial circuits partially or minimally observed on the epicardium:
Out of the 23 reentrant circuits analyzed, the majority (n=16) were observed
at the epicardium for less than 65% of the rotation cycle. In such cases, it is
important to note that the epicardial breakthrough – even if closely localized
by ECGi – may be far away from the critical components of the circuits and
may be of limited clinical value.
In the 16 cases analyzed, the epicardial breakthrough follows the endocardial breakthrough with a delay of 26 ± 50 ms. In 8 cases where this delay was
small (≤ 50 ms), the epicardial breakthrough was reasonably close to the endocardial exit as illustrated in F igure 5.9A-B: ECGi localization of epicardial
breakthroughs in such cases was thus likely to be reasonably close to the actual circuit exit, although at the wrong surface. In the cases where this delay
was large (> 50 ms), the epicardial breakthrough became far away from the
actual circuit as illustrated in F igure 5.9C-D: they may have limited clinical
value due to their distances to the actual circuits.
In a small number of cases (n=3), simulated epicardial activation was
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Figure 5.9: Breakthroughs on epicardium, first row breakthroughs on epicardium from sumlation data, second row is breakthroughs on epicardium
from ECGi data.

less organized and revealed minimal information about the circuits. These
included a mid-myocardial circuit with focal activation on the epicardium, a
3D septal circuit whose rotation was minimally observed on the epicardium,
and a 3D sub-endocardial circuit at the apex of the LV. ECGi failed to localize
the epicardial breakthroughs in these cases (F igure 5.9E-F).
3D circuits fully or mostly observed circuit on the epicardium:
The rest of the seven circuits, while being 3D in nature, were observed more
than 65% of the activation cycle at the epicardium. ECGi localized the epicardial breakthrough sites for these cases at an accuracy of 8.63 ± 3.13 mm.
Below we analyzed in detail the extent to which ECGi was able to delineate
the critical components of these circuits.
In three out of these seven circuits, full activation of the reentrant circuits can be observed on the epicardium, including the isolated local activity
within the isthmus (F igure 5.4.2A1-C1). In one of these circuits, ECGi reconstructed a full rotation, with the anchor point moving around a path (white,
F igure 5.4.2A2) that overlapped with the trajectory of the reentrant circuit
delineated from the simulation data (white, F igure 5.4.2A1). While it is possible to obtain a rough localization of the exit of the circuit from this result
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Figure 5.10: Ishcronal map with anchor tracker to shows the ability of ECGi
of capturing the global activation.

(localization error = 10.65 mm), it is not clear how to further discern the entrance or central isthmus from the reconstructed rotation. For the other two
cases, ECGi was able to localize the epicardial breakthrough (10.57 mm for
F igure 5.4.2B1 and 7.14 mm for F igure 5.4.2C1) and the following activation
pattern. It however was not able to reconstruct the local protected activation that reentered through the central isthmus of the circuit: as illustrated
in F igure 5.4.2B2-C2, this portion of the activity was missing from ECGi
reconstructions, until the next epicardial breakthrough was captured for the
next VT cycle.
In the other four circuits, a portion of the activation – in particular the
protected local activity in the central isthmuses – was not observed on the epicardium in the simulation data (F igure 5.11A1-D1). In two of these circuits,
ECGi artificially reconstructed a full rotation with the spatially-meandering
anchor point (F igure 5.11A2-B2). How well the trajectory of this anchor
overlapped with the trajectory of the simulated circuits appeared to depend
on the size of the circuit as it is observed on the epicardium.
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Figure 5.11: Ishcronal map with anchor tracker to shows the ability of ECGi
of capturing the global activation.

The reentrant circuit in F igure 5.11A1 was relatively large as observed
on the epicardium because the circuit appeared to be parallel to the epicardium, such that the exit and entrance appeared to be on the two sides of
the myocardial scar observed on the epicardium. The epicardial activation,
therefore, can be said to well reflect the trajectory of the reentrant circuits.
In this case, ECGi reconstruction accurately localized the epicardial breakthrough site (3.63 mm), and the trajectory of the anchor overlapped with that
of the simulated reentrant circuit: the only distinction was that, instead of
the absent activation in the simulation when the circuit was presumably going
through the central isthmus beneath the epicardium, ECGi introduced artificial activity in the form of a large wavefront that fully completed the rotation.
As a result, without taking the scar tissue into consideration, from ECGi reconstruction alone it would be difficult to differentiate the exits, entrance, and
central isthmus of the reentrant circuits. In comparison, the reentrant circuit
in F igure 5.11B1 was relatively small as observed on the epicardium because
the trajectory of the circuit was almost perpendicular to the epicardium. The
epicardial activation, therefore, did not well reflect the location of the entrance or central isthmus of the actual 3D circuit. In this case, while ECGi

CHAPTER 5. CHARACTERIZING 3D REENTRANT VENTRICULAR TACHYCARDIA54

reconstruction captured the main activation pattern on the epicardium, the
anchor trajectory of the reconstruction was further away from the epicardial
breakthrough of the simulated circuits (13.13 mm). Furthermore, similar to
the previous case, instead of missing activation corresponding to local activity
within the isthmus beneath the epicardium, ECGi reconstructed an artificial
wavefront that completed the full rotation. In this case, while the ECGi epicardial breakthrough roughly localizes the actual circuit breakthrough on the
epicardium, it provided limited information for the rest of the circuit components.
In the other two cases, ECGi results were similar to those in F igure
5.4.2B-C: it was able to localize the epicardial breakthrough (8.51 mm for
F igure 5.11C and 6.78 mm for F igure 5.11D) and the following activation
pattern. The portion of circuit activity absent in the simulated circuits was
not present in ECGi constructions either, although some false-positive activities appeared to be introduced, perhaps an attempt of ECGi to explain data
that was generated by activities beneath the surface.

5.4.3

Inferring Beneath the Surface

After calculating the distances and the times for all cases and looking at the
correlation between the transmural distance and surface distance versus the
difference in time of the breakthroughs in the simulation data, we noticed
that there is a good relationship, where the R-square (R2 ) is equal to 0.76.
Similarly, we calculated the distances and the times for all cases and looked at
the correlation between the transmural distance and surface distance versus
the difference in time of the breakthroughs in the ECGi data, and the (R2 )
showed that we have less correlation in ECGi data (R2 ) = 0.45. (F igure 5.12)
illustrates the results for the simulation and the ECGi data.

5.5

Conclusion and Discussion

These simulated reentrant circuits provided valuable validation data to evaluate the performance of ECGi in categorizing 3D reentrant circuits. ECGi
simultaneous epi-endo mapping can be utilized to provide essential information about the reentrant circuits even when there is more than one surface
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Figure 5.12: Correlations between surface and transmural distance vs. Epiendo breakthrough time difference, (A) relationship of the simulation data,
(B) relationship of the ECGi data.

involved. This study showed that the ECGi epi-endo mapping could correctly
classify the reentrant circuits to either 3D circuits, where more than one surface is involved, or 2D, where only one surface is involved. Most importantly,
it showed that calculating the difference in time and location between the epiendo surfaces’ breakthroughs may have the potential to help can help infer
the location of the exit of the VT circuit even when it is in the wall.
In the presented circuits, ECGi was able to categorize 83% of the cases
correctly; most of them were 2D endo circuits. However, the circuits that
ECGi failed to categorize correctly 17%, two of them were endo 2D cases, one
of them was a 3D circuit, and the last one was a focal case. It is still unclear
why the ECGi failed to categorize the 2D and the 3D cases even though it was
able to categorize the rest of the cases correctly. However, we think it makes
sense for the ECGi to not be able to categorize the focal (mid-myocardial)
case because it happens in the wall, and it does not develop a clear circuit
on the surfaces. Generally, we do not know whether the ECGi is able to categorize 3D uniform circuits because, in our original data, there were no 3D
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uniform circuits. All the 3D cases that the ECGi was able to categorize were
3D non-uniform circuits.
Identifying the location of the VT exit, even if it is in the wall using the
location and the timing of the two surfaces’ breakthroughs, is an interesting
finding. Even if this idea– based on our primary results– in the ECGi did
not appear to be robust enough, it still could give clinicians an initial sense
of whether an exit is near the endocardium, epicardium, or in the mid-way
without spending plenty of time using different mapping techniques or ablate
in different locations.
Clinical validation data for ECGi are in general a significant challenge.
This is especially the case for reentrant VT circuits because the actual morphology of the circuits is rarely known in practice – let alone the 3D construct
of the circuit. This type of data might be acquired using animal models and
present a natural direction for the next step of this study.

Chapter 6

Association of Noninvasive
ECGi with MRI Scar Imaging
6.1

Introduction

As we discussed earlier, all previous ECGi studies were limited to qualitative
validation of the ECGi-identified VT exit sites and reentrant patterns. This is
largely due to the lack of gold-standard data regarding the VT circuit and the
culprit conducting channels. Limited quantitative validation studies include
two animal case studies that involve a torso-tank set up [18], and a recent
human case study where ECGi solutions were compared to both late Gadolinium enhanced cardiac magnetic resonance (LGE-CMR) data and cathether
mapping data [68].
In this dissertation, we evaluate ECGi solutions with respect to highresolution LGE-CMR imaging of myocardial scar. We first consider the association between sinus-rhythm ECGi-computed electrical features and LGECMR identified scar tissue. We then analyze the morphology and exit sites of
ECGi-computed VT circuits with respect to the morphology and critical channels identified from LGE-CMR images. We demonstrate the electroanatomical
associations between ECGi and CMR data and argue that integrated MRIECGi analysis may provide important insights into the understanding of a VT
circuit.
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Figure 6.1: Summary of animal-model study procedure.
.

6.2

Materials and Data

The animal model protocol used in this study – as illustrated in F igure 6.1,
was approved by the University Animal Care and Use Committee of the Johns
Hopkins University School of Medicine.

6.2.1

Animal Model Creation

Eight swine models (35-45 kg) underwent creation of myocardial infarction
(MI) by inserting a guiding catheter into the left coronary artery and occluded
left anterior descending coronary artery using an angioplasty balloon [69].

CHAPTER 6. ASSOCIATION OF NONINVASIVE ECGI WITH MRI SCAR IMAGING59

6.2.2

LGE-CMR for Scar Imaging:

LGE-CMR was performed 8-10 weeks after the creation of MI using a 3-T
scanner (Prisma, Siemens Healthcare). LGE-CMR imaging was performed
20-30 minutes after injection of Gadopentetate dimeglumine 0.20 mmol/kg
(Magnevist, Bayer, Leverkusen) using a free-breathing navigator-gated threedimensional inversion recovery T1w sequence. Typical imaging parameters
were TI = 400 ms, flip angle = 25◦ , TR/TE = 5.4/2.7 ms, reconstructed pixel
size 1.1×1.1×1.1 mm with interpolation in the slice direction, 12 segments per
imaging window, GRAPPA acceleration factor (R)=2, FOV =300 × 220 mm,
matrix 272 × 200, bandwidth =200 Hz/Pixel, scan time =15-20 min.

6.2.3

Electroanatomical Mapping with Simultaneous 120-lead
ECG

One week after the LGE-CMR, an electrophysiological study was performed.
Prior to the electrophysiological study, 18 strips of 120 ECG electrodes were
placed on the swine torso. In heparinized animals, endocardial mapping of the
left ventricle was performed during sinus rhythm via a retrograde approach
using a duodecapolar (20-electrode) catheter (AfocusII, 1-2.5-1mm interelectrode spacing, 1-mm electrode size, St. Jude Medical, Minnetonka, MN) with
the NavX mapping system. To induce VT, programmed ventricular stimulation was performed from 2 right ventricular sites with up to 3 extra stimuli
decremented to ventricular refractoriness.
Body-surface ECG was recorded using the standard Dalhousie mapping
protocol [70]. Later, to record surface ECG during induced VT, 10 surface
electrodes had to be removed to accommodate the placement of NavX pads.
The rest of the electrodes remained attached to the body.

6.2.4

MRI Anatomical Imaging:

Stacks of 2D MRI images were performed to identify the ECG electrodes.
Imaging parameters for a T1-weighted gradient echo sequence with fat suppression were: reconstructed pixel size 1.1×1.1×1.1 mm, FOV = 400 × 400
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mm, matrix 384 × 307, bandwidth = 620 Hz/Pixel, breath hold for 20 seconds [68].

6.3

Method

ECGi pipeline used in this study is illustrated in the chp:Foundation, with
three main components: 1) 120-lead body-surface, 2) the forward model constructed from subject-specific heart-torso models,3) and the inverse method.

6.3.1

Delineation of CMR Scar and Surviving Channels

From CMR structural data, we delineated the 3D heterogeneous structure of
the myocardial scar as well as the potential surviving channels within the scar.
The presence of the latter was also corroborated by the analysis of local abnormal EGM characteristics obtained by contact mapping.
High-resolution CMR images were analyzed using the ADAS-VT software
(Galgo Medical, Barcelona, Spain). In specific, the detailed distributions of
myocardial scar core, gray zone, and viable tissue were delineated at 10%−90%
layer of the left ventricular wall, at a 10% interval. Potential surviving channels
within the myocardial scar in each left ventricular layer were then automatically determined by the ADAS-VT software. F igure 6.2 gives examples from
two swine hearts, showing the heterogeneous scar and surviving channels delineated by the ADAS-VT software at different myocardial layers.
Because CMR-based channel delineation considers only structural data
and is yet well understood, we further support the findings of CMR-derived
channels using contact mapping data. This was done through a set of electrical analyses depending on the availability of contact mapping data. Primarily,
in swine hearts where VT was induced, we performed a detailed analysis of
the EGM characteristics obtained during sinus rhythm to identified sites with
double, delayed, or fractionated potential. If contact mapping was possible
during induced VT, we also examined the recorded EGM to identify sites
with early-systolic or mid-diastolic potential and attempted to construct the
activation map of the VT circuits, as illustrated in F igure 6.3.
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Figure 6.2: Scar map obtained from ADAS-VT at 10%, 60%, and 90% of the
ventricular wall

Figure 6.3: Invasive analysis, (A) analysis of a voltage map extracted from
NavX, (B) activation time map of a different case showing the pattern of the
wavefront.

6.3.2

Joint MRI-ECGi Analysis

Joint MRI-ECGi analyses were carried out in both sinus rhythm and induced
VT. F igure 6.4 gives an example for each of the sinus-rhythm and VT analysis
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scenarios. Overall, as described, we considered CMR-derived scar and surviving channels, while using contact mapping as secondary supporting data.

Figure 6.4: Examples of results from ECG pre-processing during sinus-rhythm
(A) and induced VT (B).
In sinus rhythm, we extracted three features from ECGi bi-ventricular surface: voltage, duration, and the number of deflections.
The voltage of ECGi signals was calculated as the difference between the
highest and lowest deflections of each EGM. The duration of ECGi signals
was manually measured from the onset of the Q-wave to the offset of the Swave. The number of deflections, as illustrated in F igure 6.5, was counted as
the summation of either negative or positive deflections in each ECGi signal.
These features were associated with the tissue type of scar core, gray zone,
and viable myocardium as delineated by DCE-CMR, using the Spearman correlation test. While similar analyses were previously performed to associate
contact mapping EGM characteristics to DCE-CMR scar data [71], to our
knowledge this is the first time ECGi-reconstructed electrical data were quantitatively evaluated against the heterogeneous CMR data in this manner.
In VT, ECGi-reconstructed activation circuits were analyzed in two means.
On one hand, phase mapping as detailed in [72] was used to visualize the
sequential spatiotemporal evaluation o the activation wavefront. On the other
hand, local activation time was extracted from ECGi signals as the time of
maximum negative derivative of the signal. A threshold on the EGM voltage
was also used to determine regions without electrical activation – the effect
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Figure 6.5: Identifying the deflection points, blue stars show which of the
deflections were counted as fraction.

of this threshold value on the results of the activation time will be discussed
in the results. The resulting activation circuit, both in the form of a static
activation time map or a dynamic phase-mapping based activation sequence,
was analyzed visually with respect to the 3D myocardial scar and surviving
channels delineated from DCE-CMR.

6.4
6.4.1

Results
Association Between ECGi Features and CMR Scar Data

Pooling all sinus-rhythm results from six animals, we associated each of the
two ECGi features – voltage and duration – to the three CMR-identified tissue
groups (healthy, scar core, and gray zone) using a spearman’s correlation test.
Both features were positively associated with CMR tissue types (p < 1e-10).
As shown in F igure 6.6, on the epicardium, ECGi voltage in scar core (1626.7
± 707.8 mV) and gray zone (1662.5 ± 703.7 mV) was significantly lower than
that in the healthy myocardium (1973.6 ± 797.2 mV). This observation held
for the endocardial results, although the endocardial voltage was in general
lower than that of the epicardium (healthy: 626.8 ± 538.2 mV; scar core:
536.7 ± 547.7 mV; gray zone: 509.2 ± 513.8 mV).
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Figure 6.6: ECGi features, (A) epicardial and endocardial ECGi voltage in
CMR healthy, scar core, and border zones, (B) epicardial and endocardial
duration in CMR healthy, scar core, and gray zones.

Figure 6.7: Visual comparison of scar maps obtained by LGE-CMR, in-vivo
catheter voltage mapping, and each of the ECGi features.
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Figure 6.8: Critical channels as identified by CMR and catheter mapping
analysis (left two columns), versus locations of the earliest activation (exit,
column three) and the latest activation (entrance, column four) as suggested
by ECGi reconstructed VT circuit. CMR scar is superimposed with ECGi
circuit in the gray patch).

In comparison, on the epicardium, ECGi QRS duration was shorter in the
healthy myocardium (68.4 ± 32.8 ms) in comparison to that of the scar core
(80.1 ± 41.2 ms) and the gray zone (78.2 ± 40.2 ms). This observation again
held for the endocardium, where the ECGi QRS duration was 72.1 ± 26.5 m
in the healthy myocardium in comparison to 79.1 ± 29.0 ms and 79.4 ± 27.0,
respectively, for the scar core and gray zone.
For visual comparison, F igure 6.7 shows endocardial examples from two
animals where CMR scar maps and in-vivo bipolar voltage maps of scar were
compared to two ECGi feature maps: ECGi voltage maps and ECGi duration
maps, both thresholded to detect the region of the scar. As shown, ECGi
features maps, especially the voltage maps, were qualitatively consistent with
CMR scar maps in the location and extent of the scar tissue.
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Figure 6.9: Critical channels, (A) channels were identified by catheter mapping and CMR, (B) phase mapping sequences of ECGi reconstructed VT circuits on the same case shown in panel A.

6.4.2

VT Circuits with Respect to CMR-delineated Scar and
Critical Channels

Preliminary analyses were carried out to visually inspect the morphology of
the ECGi-reconstructed VT circuits with respect to CMR scar and especially
the anatomically identified critical channels.
F igure 6.8 provides an example where, in a case with the anteroseptal
myocardial scar, a critical channel was identified by the ADAS-VT software
at the basal region of the scar near the epicardium of the heart. This channel
was supported by relatively higher voltage compared to the low-voltage scar
in bipolar catheter maps. ECGi-reconstructed VT circuits exhibited an exit
from the scar at the anteroseptal region. After the exit, the circuit encountered an evident conduction block exactly at the region of the CMR scar (a
gray patch in F igure 6.8). Most interestingly, the latest activation again was
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basal to the anteroseptal scar, in a location next to the exit. This supports
the anatomical channel as identified by the CMR scar.
F igure 6.9A provides another example where an anteroseptal channel was
identified in the CMR at the middle of endocardial layer, again supported by
catheter voltage data. F igure 6.9B shows snapshots from the phase mapping
sequence of the ECGi VT circuits. As shown, an epicardial breakthrough
was observed at the anteroseptal region of the heart near the border of the
CMR scar. This circuit then exhibited a re-entrance to the anteroseptal scar,
at a location basal to the exit. This pattern again indicates a consistency
to the anatomical channel as identified from the CMR data. Additionally, a
conduction block at the CMR scar was also observed in this ECGi circuit.

6.5

Conclusion and Discussion

This part of the dissertation demonstrated the feasibility of combing the epiendo ECGi mapping with MRI scar for identifying scar substrate and VT
exits. For scar substrate, ECGi agreed with MRI scar data. This analysis was
done quantitatively, where three features were used to extract the ECGi scar.
Two of them (voltage and QRS duration) were statically significant, whereas
the third feature (multiple defalcations) was not as significant. We think the
reason could go back to the way that we processed the ECG data, where filters
were applied to reduce the noise, but we may have cleaned the signals more
than we should have done, and this of course would straighten the multiple
deflections. Going back and re-processing the ECG signals may help this feature to play a better role in identifying regions of scar to match better the
MRI scar. For VT exits, ECGi was consistent with the channels identified by
MRI. The two maps used in this section of the dissertations (phase mapping
and activation time map) have shown the behavior of the VT circuits and how
they agreed with the MRI channels.
Combining the electrical and anatomical information together in a noninvasive manner may help clinicians have a better idea of the behavior of the
VT circuits and their substrates. MRI is acquired mostly in every Electrophysiology (EP) lab either prior or after the surgery and since it is a non-invasive
technique, this may give the ECGi a bigger role to play in the EP labs, es-
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pecially before the surgery to be combined with MRI and help reveal regions
of interest. There are a few things that are needed to be addressed in the future in both sinus rhythm and VT that may help improve the outcome of this
combination, though. In sinus rhythm, the pr-process of the noisy ECG signals needs to be done carefully by removing all the noise obscuring the signals
only, without removing the other deflections, which may help later in ECGi to
identify regions of scar and channels. In VT, using other post-analysis methods may help show more information about the critical components of the VT
channels.

Chapter 7

Summary
7.1

Conclusion

This dissertation aims to investigate the ability of non-invasive simultaneous epi-endo mapping in ventricular tachycardia to provide useful information
about scar-related VT. This was done by answering to research questions: 1)
Is simultaneous epi-endo ECGi (reconstructing signals on the outer and inner
layers of the heart) able to reveal the 3D morphology of reentrant circuits,
and 2) Is the integration of ECGi and MRI able to help delineate the critical
channel for reentrant circuits.
For the first research question, we demonstrated the ability of simultaneous
epi-endo ECGi mapping of revealing regions of VT substrate during the sinus
rhythm and short-lived circuits during the VT. Moreover, we showed that the
epi-endo ECGi mapping is able to categorize the reentry circuits, whether 3D
or 2D. More importantly, we have shown that the ECGi can also reveal critical
components of the VT circuits. This finding may help improve and accelerate
the process of localizing the VT circuit and what type of circuit clinicians are
dealing with. Additionally, we have used the locations and the times of the
breakthroughs on both layers to infer the location of the VT exit. This novel
finding may help clinicians find the exit site using the available information
on both layers.
For the second research question, we carried out a detailed analysis on
69
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combining anatomical and electrical information. This may help assess the
arrhythmogenic substrate in relation to the arrhythmia circuit, which could
help assess the mechanism of VT and identify the ablation target. Our results
also showed that the ECGi technique could provide information that aligns
decently with the MRI data to help locate early depolarization sites during the
VT. Overall, this dissertation research will help clinicians plan for the ablation
ahead of the treatment procedure. This will help them focus on certain things,
such as the VT circuits’ critical components, the surfaces that are involved,
and the 3D morphology of the VT circuits, which can contribute to better
treatment outcomes.

7.2

Future Work

This dissertation showed how epi-endo mapping can help understand the behaviors of the VT circuit. Several interesting directions of future works can
help improve the quality of epi-endo mapping to localize the VT circuits. In
this section, we will break the future work into three main parts:
• To improve simultaneous epicardial and endocardial mapping for VT:
1. In our first step into the identifications of the substrate of the VT,
we tried to identify features of the signals during the sinus rhythm to
help localize the location of the VT exit. We did that using a short
sinus rhythm recording in which we could not extract more features
that might be relevant to the VT exit. In the future, we would
acquire longer sinus rhythm data and apply the signal averaging
to it. The signal averaging is a signal processing technique applied
in the time domain, used to help increase the strength of a signal
relative to noise obscuring it. After that, we would try to identify
more features that might help improve the accuracy of the ECGi
VT mapping during the sinus rhythm.
2. Using different post-analysis tools to find the correct location of
the VT circuits may not be enough, where the pre-processing steps
usually take plenty of time. For example, the wave-front extracted
from the phase mapping helps show the VT reentry circuits locations. However, there’s a lot to be done before identifying the location of the VT circuits. To help accelerate the process, we may need
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to find an alternative approach that automatically extracts useful
features from the signals and identifies the VT circuit regions.
3. Current invasive methods are mapping only one surface at a time.
This type of mapping can’t provide the optimal data for the ECGi
community to test the epi-endo ECGi mapping. Collaborating with
groups that use contact mapping to apply epi-endo mapping and
apply the methods that we have tried in this dissertation can help
researchers understand the scar-related VT better.
4. We have applied a simple linear regression model to find a rough
location of the exit site in the 3D. It will be interesting to see the
results if an advanced machine learning model is applied to do back
calculations to find those distances and to find the location of the
exit.
• To improve the combination of ECGi and MRI scar analysis to help identify locations and morphologies of the VT circuits during sinus rhythm
and VT:
1. We have not seen any study that included the MRI scar information to the ECGi pipeline. Recent studies focus on improving the
ECGi methods without considering the scar information as an additional source. As we know, identifying the VT circuit or the slow
conduction region is very challenging and requires two information
sources, electrical and anatomical. Relying only on the electrical
information doesn’t provide enough information about those small
regions. Thus, adding such information will help guide the ECGi
to provide more robust outcomes.
• To validate the outcome of the ECGi for scar-related VT in general:
1. In-vivo data for the VT circuits are unavailable. This has affected
the ability of the ECGi to improve, making it very difficult for ECGi
to be validated. We believe in acquiring medical data that can
provide detailed validation data that can help improve the ECGi
results.
2. The availability of the validating data for the ECGi is limited, where
it’s infrequent to have more than one type of validation data. Thus,
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we believe having different clinical validation data, such as voltage
map, activation time map, ablation sites, and MRI scar and channels, may help understand the behavior of VT circuits.
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